XORTX Therapeutics Ownership 2024 | Who Owns XORTX Therapeutics Now?
Institutional Ownership
0.65%
Insider Ownership
3.19%
Retail Ownership
96.16%
Institutional Holders
4.00
XORTX Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | - | - | - | -2 | -100.00% | - | Dec 31, 2023 |
| CLEARSTEAD ADVISORS, LLC | - | - | - | -2,500 | -100.00% | - | Dec 31, 2023 |
| TORONTO DOMINION BANK | - | - | - | -53 | -100.00% | - | Dec 31, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -10,383 | -100.00% | - | Dec 31, 2023 |
XORTX Therapeutics's largest institutional shareholder is BANK OF AMERICA CORP /DE/, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | - | - | - | -2 | -100.00% | - | Dec 31, 2023 |
| CLEARSTEAD ADVISORS, LLC | - | - | - | -2,500 | -100.00% | - | Dec 31, 2023 |
| TORONTO DOMINION BANK | - | - | - | -53 | -100.00% | - | Dec 31, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -10,383 | -100.00% | - | Dec 31, 2023 |
The largest XORTX Therapeutics shareholder by % of total assets is BANK OF AMERICA CORP /DE/. The company owns 0.00 shares of XORTX Therapeutics (XRTX), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | - | - | - | -2 | -100.00% | - | Dec 31, 2023 |
| TORONTO DOMINION BANK | - | - | - | -53 | -100.00% | - | Dec 31, 2023 |
| CLEARSTEAD ADVISORS, LLC | - | - | - | -2,500 | -100.00% | - | Dec 31, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -10,383 | -100.00% | - | Dec 31, 2023 |
As of Dec 31 2023, XORTX Therapeutics's largest institutional buyer is BANK OF AMERICA CORP /DE/. The company purchased -2.00 stocks of XRTX, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -10,383 | -100.00% | - | Dec 31, 2023 |
| CLEARSTEAD ADVISORS, LLC | - | - | - | -2,500 | -100.00% | - | Dec 31, 2023 |
| TORONTO DOMINION BANK | - | - | - | -53 | -100.00% | - | Dec 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -2 | -100.00% | - | Dec 31, 2023 |
As of Dec 31 2023, XORTX Therapeutics's biggest institutional seller is ADVISOR GROUP HOLDINGS, INC.. The company sold -10.38K shares of XRTX, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -10,383 | -100.00% | - | Dec 31, 2023 |
| CLEARSTEAD ADVISORS, LLC | - | - | - | -2,500 | -100.00% | - | Dec 31, 2023 |
| TORONTO DOMINION BANK | - | - | - | -53 | -100.00% | - | Dec 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -2 | -100.00% | - | Dec 31, 2023 |
XORTX Therapeutics's largest sold out institutional shareholder by shares sold is ADVISOR GROUP HOLDINGS, INC., sold -10.38K shares, valued at -, as of undefined.
XORTX Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Sep, 23 | 4 | - |
| 30 Jun, 23 | 4 | -33.33% |
| 31 Mar, 23 | 6 | -14.29% |
| 31 Dec, 22 | 7 | 133.33% |
| 30 Sep, 22 | 3 | - |
| 30 Jun, 22 | 3 | -40.00% |
| 31 Mar, 22 | 5 | 66.67% |
| 31 Dec, 21 | 3 | - |
As of 30 Sep 23, 4 institutions are holding XORTX Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Sep, 23 | 12,938 | -68.44% |
| 30 Jun, 23 | 40,994 | -42.62% |
| 31 Mar, 23 | 71,446 | -95.35% |
| 31 Dec, 22 | 1,535,856 | 6008.73% |
| 30 Sep, 22 | 25,142 | -25.21% |
| 30 Jun, 22 | 33,616 | -51.37% |
| 31 Mar, 22 | 69,127 | 186.07% |
| 31 Dec, 21 | 24,164 | - |
XORTX Therapeutics (XRTX) has 12.94K shares outstanding as of 30 Sep 23, down -68.44% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Sep, 23 | 0.65% | 15.44% |
| 30 Jun, 23 | 2.05% | 14.96% |
| 31 Mar, 23 | 3.70% | 0.03% |
| 31 Dec, 22 | 103.84% | 3415.87% |
| 30 Sep, 22 | 1.74% | 32.13% |
| 30 Jun, 22 | 2.33% | 10.15% |
| 31 Mar, 22 | 4.79% | 98.19% |
| 31 Dec, 21 | 2.21% | - |
As of 30 Sep 23, XORTX Therapeutics is held by 0.65% institutional shareholders, representing a 15.44% growth compared to 30 Jun 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Sep, 23 | 1 | - |
| 30 Jun, 23 | 1 | -75.00% |
| 31 Mar, 23 | 4 | -20.00% |
| 31 Dec, 22 | 5 | 150.00% |
| 30 Sep, 22 | 2 | - |
| 30 Jun, 22 | 2 | -50.00% |
| 31 Mar, 22 | 4 | 33.33% |
| 31 Dec, 21 | 3 | - |
1 institutional shareholders have increased their position in XRTX stock as of 30 Sep 23 compared to 1 in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Sep, 23 | - | - |
| 30 Jun, 23 | - | - |
| 31 Mar, 23 | - | - |
| 31 Dec, 22 | - | -100.00% |
| 30 Sep, 22 | 1 | - |
| 30 Jun, 22 | 1 | - |
| 31 Mar, 22 | - | - |
| 31 Dec, 21 | - | - |
- institutional shareholders have reduced their position in XRTX stock as of 30 Sep 23 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Sep, 23 | 4 | - | 12,938 | -68.44% | 0.65% | 15.44% | 1 | - | - | - |
| 30 Jun, 23 | 4 | -33.33% | 40,994 | -42.62% | 2.05% | 14.96% | 1 | -75.00% | - | - |
| 31 Mar, 23 | 6 | -14.29% | 71,446 | -95.35% | 3.70% | 0.03% | 4 | -20.00% | - | - |
| 31 Dec, 22 | 7 | 133.33% | 1,535,856 | 6008.73% | 103.84% | 3415.87% | 5 | 150.00% | - | -100.00% |
| 30 Sep, 22 | 3 | - | 25,142 | -25.21% | 1.74% | 32.13% | 2 | - | 1 | - |
| 30 Jun, 22 | 3 | -40.00% | 33,616 | -51.37% | 2.33% | 10.15% | 2 | -50.00% | 1 | - |
| 31 Mar, 22 | 5 | 66.67% | 69,127 | 186.07% | 4.79% | 98.19% | 4 | 33.33% | - | - |
| 31 Dec, 21 | 3 | - | 24,164 | - | 2.21% | - | 3 | - | - | - |
XRTX Ownership FAQ
Who Owns XORTX Therapeutics?
XORTX Therapeutics is owned by institutional shareholders (0.65%), insiders (3.19%), and public (96.16%). The largest institutional shareholder of XORTX Therapeutics is BANK OF AMERICA CORP /DE/ (0% of total shares) and the top mutual fund owner is (0% of total shares).
Who are the major institutional shareholders of XORTX Therapeutics?
XORTX Therapeutics's major institutional shareholders are BANK OF AMERICA CORP /DE/, CLEARSTEAD ADVISORS, LLC, TORONTO DOMINION BANK, and ADVISOR GROUP HOLDINGS, INC.. The top five shareholders own together 0% of the company's share outstanding.
How many XORTX Therapeutics shareholders are there?
As of Sep 2023, there are 4 institutional shareholders of XORTX Therapeutics.
What percentage of XORTX Therapeutics is owned by BANK OF AMERICA CORP /DE/?
BANK OF AMERICA CORP /DE/ owns 0 shares of XORTX Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).
What percentage of XORTX Therapeutics is owned by CLEARSTEAD ADVISORS, LLC?
As of Dec 2023, CLEARSTEAD ADVISORS, LLC holds 0 shares of XORTX Therapeutics (XRTX), compromising 0% of the company, valued at $0.
What percentage of XORTX Therapeutics is owned by TORONTO DOMINION BANK?
TORONTO DOMINION BANK is the third largest holder of XORTX Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).